Category: Precision Patient Outcomes Inc.

FTC-PR-240215-1

FTC-PR-240215-1 (Feb. 15, 2024) FTC Order Will Ban California-based Company from COVID-19 Advertising Claims – Case was part of the Commission’s efforts to combat COVID-related health fraud The Federal Trade Commission today announced a proposed settlement that would ban California-based Precision Patient Outcomes, Inc. (PPO) and the company’s CEO Margrett Priest Lewis from claiming that […]